Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Clinical and mutational profiles of microsatellite instability (MSI-H) in intrahepatic cholangiocarcinoma (iCCA).
Authors
Madhulika Eluri
MD Anderson Hematology/Oncology Fellowship, Houston, TX;
Madhulika Eluri , Anaemy Danner De Armas , Jeffrey S. Ross , Radwa Sharaf , Dean C. Pavlick , Deyali Chatterjee , Milind M. Javle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 607)
DOI
10.1200/JCO.2023.41.4_suppl.607
Abstract #
607
Poster Bd #
F19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Landscape of BRAF mutation classes in intrahepatic cholangiocarcinoma.
First Author: Tin-Yun Tang
Poster
2020 ASCO Virtual Scientific Program
Genomics and translational precision oncology for 803 patients with biliary tract cancer.
First Author: Jianzhen Lin
Poster
2019 ASCO Annual Meeting
Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable alterations in advanced cholangiocarcinoma.
First Author: Ian M. Silverman
Poster
2018 Gastrointestinal Cancers Symposium
Lenvatinib plus checkpoint inhibitors in patients (pts) with advanced intrahepatic cholangiocarcinoma (ICC): Preliminary data and correlation with next-generation sequencing.
First Author: Jianzhen Lin